National Bank Of Canada Astrazeneca PLC Transaction History
National Bank Of Canada
- $72.7 Billion
- Q3 2024
A detailed history of National Bank Of Canada transactions in Astrazeneca PLC stock. As of the latest transaction made, National Bank Of Canada holds 158,329 shares of AZN stock, worth $10.5 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
158,329
Previous 158,329
-0.0%
Holding current value
$10.5 Million
Previous $12.3 Million
-0.0%
% of portfolio
0.02%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding AZN
# of Institutions
1,360Shares Held
476MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.17 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.79 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.47 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.44 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.3MShares$1.28 Billion0.43% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $206B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...